Literature DB >> 7647625

New developments in hepatitis A control.

L Yuan1.   

Abstract

An inactivated vaccine for hepatitis A was recently licensed in Canada. This is the first important development in control of the disease in 50 years. This article presents new information about the vaccine and about the groups who might benefit from it. It also provides a review of the clinical and epidemiological aspects of hepatitis A.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7647625      PMCID： PMC2146181     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  29 in total

1.  Propagation of human hepatitis A virus in cell culture in vitro.

Authors:  P J Provost; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

2.  Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578).

Authors:  P J Provost; B S Wolanski; W J Miller; O L Ittensohn; W J McAleer; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

Review 3.  Type A viral hepatitis. New developments in an old disease.

Authors:  S M Lemon
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

4.  Hepatitis A--investigation and control of outbreaks in two primary schools.

Authors:  J Reid; J M Carter
Journal:  Public Health       Date:  1986-03       Impact factor: 2.427

5.  Stability of hepatitis A virus.

Authors:  G Siegl; M Weitz; G Kronauer
Journal:  Intervirology       Date:  1984       Impact factor: 1.763

6.  Prevalence and incidence of hepatitis A among male homosexuals.

Authors:  R A Coutinho; P Albrecht-van Lent; N Lelie; N Nagelkerke; H Kuipers; T Rijsdijk
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

7.  Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

Authors:  S M Feinstone; A Z Kapikian; R H Purceli
Journal:  Science       Date:  1973-12-07       Impact factor: 47.728

8.  An outbreak of hepatitis A among health care workers: risk factors for transmission.

Authors:  B N Doebbeling; N Li; R P Wenzel
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

9.  Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection.

Authors:  J L Dienstag; F M Davenport; R W McCollum; A V Hennessy; G Klatskin; R H Purcell
Journal:  JAMA       Date:  1976-08-02       Impact factor: 56.272

10.  Posttransfusion hepatitis type A.

Authors:  F B Hollinger; N C Khan; P E Oefinger; D H Yawn; A C Schmulen; G R Dreesman; J L Melnick
Journal:  JAMA       Date:  1983-11-04       Impact factor: 56.272
View more
  1 in total

1.  Double dose of protection.

Authors:  S Sax
Journal:  Can Fam Physician       Date:  1995-10       Impact factor: 3.275
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.